This training will review the components of a successful CMS reimbursement strategy and outline the advantages of implementing the strategy early in the medical device development process.
Why Should You Attend:
Ask most new medical device manufacturers which was the more difficult, getting FDA clearance or obtaining reimbursement approval from the Centers for Medicare and Medicaid (CMS), and you will likely hear horror stories regarding the latter. Medicare (the largest third-party payer for medical procedures) is limited by law to cover only technologies that are "reasonable and necessary" for diagnosis and treatment.
Private payers typically adopt the same policies for coverage, coding and payment as Medicare. This means that new device manufacturers must meet Medicare's bundled payment requirements or qualify for reimbursement on their own. In turn, this means additional effort and time to get to revenue-generation.
This session will concentrate on the components of a successful reimbursement strategy and methods of implementing the strategy early in the medical device development process.
At the end of the webinar, participants will understand the process for integrating a reimbursement strategy into their medical device development plan. They will understand the importance of working their strategy into the early stages of development and be armed with methods for minimizing time from regulatory approval to revenue-generation.
Added by complianceonlinecom on March 27, 2013